Cargando…

miR-4324 inhibits ovarian cancer progression by targeting FEN1

BACKGROUND: Ovarian cancer is one of the most lethal malignancies, with a 1.9% mortality rate worldwide. The dysregulation of the FEN1 gene and miR-4324 has been associated with cancer progression. However, the relationship between miR-4324 and-FEN1 requires further investigation. METHODS: miR-4324...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Haixia, Yan, Youliang, Yuan, Jialin, Luo, Mengze, Wang, Yingjian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896303/ https://www.ncbi.nlm.nih.gov/pubmed/35246224 http://dx.doi.org/10.1186/s13048-022-00959-5

Ejemplares similares

miR-4324 functions as a tumor suppressor in colorectal cancer by targeting HOXB2
por: Li, Hailin, et al.
Publicado: (2019)

RETRACTION NOTICE: miR-4324 functions as a tumor suppressor in colorectal cancer by targeting HOXB2
Publicado: (2021)

Metformin sensitises osteosarcoma to chemotherapy via the IGF-1R/miR-610/FEN1 pathway
por: Dong, Suwei, et al.
Publicado: (2023)

miR-193b Increases the Chemosensitivity of Osteosarcoma Cells by Promoting FEN1-Mediated Autophagy
por: Dong, Suwei, et al.
Publicado: (2019)

rs4246215 is targeted by hsa-miR1236 to regulate FEN1 expression but is not associated with Fuchs’ endothelial corneal dystrophy
por: Nanda, Gargi Gouranga, et al.
Publicado: (2018)

LncRNA-MSC-AS1 inhibits the ovarian cancer progression by targeting miR-425-5p
por: Zhao, Yinling, et al.
Publicado: (2021)

MiR-494 Inhibits Epithelial Ovarian Cancer Growth by Targeting c-Myc
por: Yuan, Jialing, et al.
Publicado: (2016)

4324 Phase 1 Sterile Product Formulation and Manufacturing at Academic Medical Centers: An Introduction for Translational Researchers
por: MacArthur, Robert Bruce, et al.
Publicado: (2020)

Doxorubicin inhibits osteosarcoma progression by regulating circ_0000006/miR-646/ BDNF axis
por: Amuti, Abulimiti, et al.
Publicado: (2021)

Revision of the calcareous fen arachnofauna: habitat affinities of the fen-inhabiting spiders
por: Štokmane, Maija, et al.
Publicado: (2018)

Targeting of KDM5A by miR-421 in Human Ovarian Cancer Suppresses the Progression of Ovarian Cancer Cells
por: Ren, Fang, et al.
Publicado: (2020)

ZNF367 Inhibits Cancer Progression and Is Targeted by miR-195
por: Jain, Meenu, et al.
Publicado: (2014)

miR-30 inhibits the progression of osteosarcoma by targeting MTA1
por: Zhao, Aiqing, et al.
Publicado: (2022)

Downregulation of microRNA-4324 promotes the EMT of esophageal squamous-cell carcinoma cells via upregulating FAK
por: Zhou, Jian, et al.
Publicado: (2019)

Yuan Fen 緣份
por: Wong, Annie N.M.
Publicado: (2022)

miR-4478 sensitizes ovarian cancer cells to irradiation by inhibiting Fus and attenuating autophagy
por: Wang, Lingling, et al.
Publicado: (2020)

miR-124 and miR-506 inhibit colorectal cancer progression by targeting DNMT3B and DNMT1
por: Chen, Zhiheng, et al.
Publicado: (2015)

MiR-1271 Inhibits Ovarian Cancer Growth by Targeting Cyclin G1
por: Liu, Xiaogang, et al.
Publicado: (2015)

Exosomal miR-543 Inhibits the Proliferation of Ovarian Cancer by Targeting IGF2
por: Zhang, Shupei, et al.
Publicado: (2022)

The FEN1 E359K germline mutation disrupts the FEN1-WRN interaction and FEN1 GEN activity, causing aneuploidy-associated cancers
por: Chung, Lin, et al.
Publicado: (2014)

miR-198 inhibits the progression of renal cell carcinoma by targeting BIRC5
por: Yuan, Chao, et al.
Publicado: (2021)

MiR-34b-3 and miR-449a inhibit malignant progression of nasopharyngeal carcinoma by targeting lactate dehydrogenase A
por: Li, Huiling, et al.
Publicado: (2016)

miR-26a inhibits atherosclerosis progression by targeting TRPC3
por: Feng, Min, et al.
Publicado: (2018)

miR-122 Inhibits Hepatocarcinoma Cell Progression by Targeting LMNB2
por: Li, Xiao-Na, et al.
Publicado: (2020)

MiR-200c inhibits bladder cancer progression by targeting lactate dehydrogenase A
por: Yuan, Daozhang, et al.
Publicado: (2017)

MiR-137 and miR-34a directly target Snail and inhibit EMT, invasion and sphere-forming ability of ovarian cancer cells
por: Dong, Peixin, et al.
Publicado: (2016)

Diagnostic and prognostic potential of serum miR-7, miR-16, miR-25, miR-93, miR-182, miR-376a and miR-429 in ovarian cancer patients
por: Meng, Xiaodan, et al.
Publicado: (2015)

miR-22 inhibits mouse ovarian granulosa cell apoptosis by targeting SIRT1
por: Xiong, Fang, et al.
Publicado: (2016)

Targeting miR-21-3p inhibits proliferation and invasion of ovarian cancer cells
por: Báez-Vega, Perla M., et al.
Publicado: (2016)

miR-145 inhibits mitochondrial function of ovarian cancer by targeting ARL5B
por: Zhao, Shuo, et al.
Publicado: (2021)

MiR‐139‐5p, miR‐940 and miR‐193a‐5p inhibit the growth of hepatocellular carcinoma by targeting SPOCK1
por: Li, Peng, et al.
Publicado: (2019)

Single-molecule characterization of Fen1 and Fen1/PCNA complexes acting on flap substrates
por: Craggs, Timothy D., et al.
Publicado: (2014)

miR-222 promotes invasion and migration of ovarian carcinoma by targeting PTEN
por: Gong, Li, et al.
Publicado: (2018)

MiR-23b targets cyclin G1 and suppresses ovarian cancer tumorigenesis and progression
por: Yan, Jing, et al.
Publicado: (2016)

miR-96 inhibits EMT by targeting AEG-1 in glioblastoma cancer cells
por: Feng, Shiyu, et al.
Publicado: (2018)

miR-539 inhibits prostate cancer progression by directly targeting SPAG5
por: Zhang, Hongtuan, et al.
Publicado: (2016)

miR-449a inhibits colorectal cancer progression by targeting SATB2
por: Sun, Xiaohua, et al.
Publicado: (2016)

MiR-200c Inhibits the Tumor Progression of Glioma via Targeting Moesin
por: Qin, Yuanyuan, et al.
Publicado: (2017)

Exosomal miR-638 Inhibits Hepatocellular Carcinoma Progression by Targeting SP1
por: Yang, Jing, et al.
Publicado: (2020)

miR‐1254 inhibits progression of glioma in vivo and in vitro by targeting CSF‐1
por: Li, Xin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ij9t8cou5v8eb9f7ntmbbtr9dv